肺心病合并冠心病患者69例临床疗效探讨

Clinical Effect Observation of 69 Cases with Pulmonary Heart Disease Complicated with Coronary Heart Disease

目的探讨慢性肺源性心脏病(肺心病)合并冠状动脉粥样硬化性心脏病(冠心病)的临床治疗方法和效果,为临床治疗提供参考。方法整群选择2014年4月—2015年4月该院收治的138例肺心病合并冠心病患者,将患者随机分为实验组、对照组,每组69例。对照组患者给予常规治疗,实验组在对照组基础上给予个体化治疗。结果实验组:显效29例(42.03%),有效34例(49.27%),无效6例(8.70%),总有效率为91.30%;对照组:有效19例(27.53%),有效31例(44.93%),无效19例(27.54%),总有效率为72.46%。实验组总有效率显著高于对照组,两组总有效率差异有统计学意义(P<0.05)。结论对肺心病合并冠心病患者在常规治疗基础上,给予个体化治疗,能明显缓解病情,减轻患者及其家庭的负担,提高治疗总有效率,降低死亡率,改善远期预后,临床意义显著。

Objective To investigate the methods for chronic pulmonary heart disease combined with coronary heart disease(CHD) and the clinical results so as to provide reference for clinical treatment of the disease. Methods 138 cases with pulmonary heart disease and coronary heart disease admitted in our hospital from April 2014 to April 2015 were selected and randomly divided into the experimental group and the control group with 69 cases in each. Patients in the control group were treated by the conventional treatment, while those in the observation group were treated by individualized and conventional treatment. Results In the experimental group, the treatment effect was remarkably effective in 29 cases(42.03%), effective in 34 cases(49.27%), ineffective in 6 cases(8.70%), the overall response rate was 91.30%. In the control group, the treatment effect was remarkably effective in 19 cases(27.53%), effective in 31 cases(44.93%), ineffective in 19 cases(27.54%), the overall response rate was 72.46%. The overall response rate of the experimental group was much higher than that of the control group with statistically significant difference(P<0.05). Conclusion For patients with pulmonary heart disease complicated by coronary heart disease, individualized and conventional treatment can significantly alleviate the condition, reduce the burden of patients and their families, improve the overall response rate, decrease the mortality as well as enhance the long-term prognosis with significant clinical significance.